FDA fully approves brexu-cel CAR‑T for relapsed mantle cell lymphoma, with ZUMA‑2 showing deep responses and key infection-care tips for clinicians. The treatment landscape for mantle cell lymphoma ...
Advanced disease progression occurred less often with vutrisiran than placebo in both the overall population (8.0% vs 10.7%) and monotherapy subgroup (8.2% vs 11.1%). Transition to NYHA class IV was ...
Abstract: The symmetrical 6-terminal pole-phase modulation (S6TPPM) induction motor drive (IMDrive) has proven to be a viable alternative to other drives in electric vehicles (EVs). The advantages of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results